1,279
Views
93
CrossRef citations to date
0
Altmetric
Review

Applications of Graphene and Graphene Oxide in Smart Drug/Gene Delivery: Is the World Still Flat?

ORCID Icon, ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 9469-9496 | Published online: 27 Nov 2020

References

  • Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013;9(12):9243–9257. doi:10.1016/j.actbio.2013.08.01623958782
  • Li Z, Fan J, Tong C, et al. A smart drug-delivery nanosystem based on carboxylated graphene quantum dots for tumor-targeted chemotherapy. Nanomedicine. 2019;14(15):2011–2025. doi:10.2217/nnm-2018-037831355696
  • Novoselov KS, Geim A. The rise of graphene. Nat Mater. 2007;6(3):183–191. doi:10.1038/nmat184917330084
  • Pinto AM, Goncalves IC, Magalhães FD. Graphene-based materials biocompatibility: a review. Colloids Surf B Biointerfaces. 2013;111:188–202. doi:10.1016/j.colsurfb.2013.05.02223810824
  • Zangabad PS, Mirkiani S, Shahsavari S, et al. Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications. Nanotechnol Rev. 2018;7(1):95–122.29404233
  • Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine. 2019;14(1):93–126. doi:10.2217/nnm-2018-012030451076
  • Farjadian F, Roointan A, Mohammadi-Samani S, Hosseini M. Mesoporous silica nanoparticles: synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. Chem Eng J. 2019;359:684–705. doi:10.1016/j.cej.2018.11.156
  • Entezar-Almahdi E, Mohammadi-Samani S, Tayebi L, Farjadian F. Recent advances in designing 5-fluorouracil delivery systems: a stepping stone in the safe treatment of colorectal cancer. Int J Nanomedicine. 2020;15:5445. doi:10.2147/IJN.S25770032801699
  • Karimi M, Ghasemi A, Mirkiani S, Basri SMM, Hamblin MR. Carbon Nanotubes in Drug and Gene Delivery. San Rafael, CA: Morgan & Claypool Publishers; 2017.
  • Fatemeh Farjadian SA, Sadatlu MAA, Mirkiani S, et al. Recent developments in graphene and graphene oxide: properties, synthesis, and modifications: a review chemistryselect. ChemistrySelect. 2020;5(33):10200–10219. doi:10.1002/slct.202002501
  • А F, Prischepa S, Fedotova J, et al. Electrical conductivity and magnetoresistance in twisted graphene electrochemically decorated with Co particles. Physica E Low Dimens Syst Nanostruct. 2020;117:113790. doi:10.1016/j.physe.2019.113790
  • Jiang J-H, Pi J, Jin H, Cai J-Y. Functional graphene oxide as cancer-targeted drug delivery system to selectively induce oesophageal cancer cell apoptosis. Arti Cells Nanomed Biotechnol. 2018;46(sup3):S297–S307. doi:10.1080/21691401.2018.1492418
  • Muñoz R, Singh DP, Kumar R, Matsuda A. Graphene oxide for drug delivery and cancer therapy In: Swain SK, Jawaid M, editors. Nanostructured Polymer Composites for Biomedical Applications.. Elsevier; 2019:447–488.
  • Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc. 2008;130(33):10876–10877. doi:10.1021/ja803688x18661992
  • Campbell E, Hasan MT, Pho C, Callaghan K, Akkaraju G, Naumov A. Graphene oxide as a multifunctional platform for intracellular delivery, imaging, and cancer sensing. Sci Rep. 2019;9(1):1–9. doi:10.1038/s41598-018-36617-430626917
  • McCallion C, Burthem J, Rees-Unwin K, Golovanov A, Pluen A. Graphene in therapeutics delivery: problems, solutions and future opportunities. Eur J Pharm Biopharm. 2016;104:235–250. doi:10.1016/j.ejpb.2016.04.01527113141
  • Singh N, Kushwaha P, Gupta A, Prakash O. Recent advances of novel therapeutic agents from botanicals for prevention and therapy of breast cancer: an updated review. Curr Cancer Ther Rev. 2020;16(1):5–18. doi:10.2174/1573394715666181129101502
  • Choi J-S, Joo SH. Recent trends in cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther (Seoul). 2020;28(1):18. doi:10.4062/biomolther.2019.08231597413
  • Kovalchuk O, Kovalchuk I. Cannabinoids as anticancer therapeutic agents. Cell Cycle. 2020;19(9):961–989. doi:10.1080/15384101.2020.174295232249682
  • Hosseini M, Farjadian F, Makhlouf ASH. Smart stimuli-responsive nano-sized hosts for drug delivery In: Hosseini, Makhlouf M, Hamdy AS, editors. Industrial Applications for Intelligent Polymers and Coatings.. Springer; 2016:1–26.
  • Abdelhamid HN, Khan MS, Wu H-F. Graphene oxide as a nanocarrier for gramicidin (GOGD) for high antibacterial performance. RSC Adv. 2014;4(91):50035–50046. doi:10.1039/C4RA07250B
  • Sun X, Liu Z, Welsher K, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 2008;1(3):203–212. doi:10.1007/s12274-008-8021-820216934
  • Goenka S, Sant V, Sant S. Graphene-based nanomaterials for drug delivery and tissue engineering. J Controlled Release. 2014;173:75–88. doi:10.1016/j.jconrel.2013.10.017
  • Lu CH, Yang HH, Zhu CL, Chen X, Chen GN. A graphene platform for sensing biomolecules. Angewandte Chemie. 2009;121(26):4879–4881. doi:10.1002/ange.200901479
  • Ahmadi S, Rabiee N, Bagherzadeh M, et al. Stimulus-responsive sequential release systems for drug and gene delivery. Nano Today. 2020;34:100914. doi:10.1016/j.nantod.2020.10091432788923
  • Robinson JT, Tabakman SM, Liang Y, et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc. 2011;133(17):6825–6831. doi:10.1021/ja201017521476500
  • Yang K, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials. 2012;33(7):2206–2214. doi:10.1016/j.biomaterials.2011.11.06422169821
  • Wang A, Long L, Zhao W, et al. Increased optical nonlinearities of graphene nanohybrids covalently functionalized by axially-coordinated porphyrins. Carbon. 2013;53:327–338. doi:10.1016/j.carbon.2012.11.019
  • Chen Y-W, Chen P-J, Hu S-H, Chen IW, S-Y C. NIR-triggered synergic photo-chemothermal therapy delivered by reduced graphene oxide/carbon/mesoporous silica nanocookies. Adv Funct Mater. 2014;24(4):451–459.
  • Tang Y, Hu H, Zhang MG, et al. An aptamer-targeting photoresponsive drug delivery system using “off-on” graphene oxide wrapped mesoporous silica nanoparticles. Nanoscale. 2015;7(14):6304–6310. doi:10.1039/C4NR07493A25782595
  • Yang K, Feng L, Liu Z. Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy. Adv Drug Deliv Rev. 2016;105(Part):B:228–241. doi:10.1016/j.addr.2016.05.015
  • Yang Y, Zhang YM, Chen Y, Zhao D, Chen JT, Liu Y. Construction of a graphene oxide based noncovalent multiple nanosupramolecular assembly as a scaffold for drug delivery. Chem Eur J. 2012;18(14):4208–4215. doi:10.1002/chem.20110344522374621
  • Wu J, Y-S W, X-Y Y, et al. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology. 2012;23(35):355101. doi:10.1088/0957-4484/23/35/35510122875697
  • Fan X, Jiao G, Gao L, Jin P, Li X. The preparation and drug delivery of a graphene–carbon nanotube–Fe 3 O 4 nanoparticle hybrid. J Mater Chem B. 2013;1(20):2658–2664. doi:10.1039/c3tb00493g32260953
  • Zhang L, Lu Z, Zhao Q, Huang J, Shen H, Zhang Z. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI‐grafted graphene oxide. Small. 2011;7(4):460–464. doi:10.1002/smll.20100152221360803
  • Shen H, Liu M, He H, et al. PEGylated graphene oxide-mediated protein delivery for cell function regulation. ACS Appl Mater Interfaces. 2012;4(11):6317–6323. doi:10.1021/am301936723106794
  • La WG, Park S, Yoon HH, et al. Delivery of a therapeutic protein for bone regeneration from a substrate coated with graphene oxide. Small. 2013;9(23):4051–4060. doi:10.1002/smll.20130057123839958
  • Zhang L, Xia J, Zhao Q, Liu L, Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2010;6(4):537–544. doi:10.1002/smll.20090168020033930
  • Öztürk-Atar K, Eroğlu H, Çalış S. Novel advances in targeted drug delivery. J Drug Target. 2018;26(8):633–642. doi:10.1080/1061186X.2017.140107629096554
  • Zhang M, Wu F, Wang W, Shen J, Zhou N, Wu C. Multifunctional nanocomposites for targeted, photothermal, and chemotherapy. Chemi Mater. 2019;31(6):1847–1859. doi:10.1021/acs.chemmater.8b00934
  • De S, Patra K, Ghosh D, et al. Tailoring the efficacy of multifunctional biopolymeric graphene oxide quantum dot-based nanomaterial as nanocargo in cancer therapeutic application. ACS Biomater Sci Eng. 2018;4(2):514–531.33418741
  • Li D, Deng M, Yu Z, et al. Biocompatible and stable GO-coated Fe3O4 nanocomposite: a robust drug delivery carrier for simultaneous tumor MR imaging and targeted therapy. ACS Biomater Sci Eng. 2018;4(6):2143–2154. doi:10.1021/acsbiomaterials.8b0002933435038
  • Chowdhury AD, Ganganboina AB, Y-C T, H-C C, R-A D. Multifunctional GQDs-Concanavalin A@ Fe3O4 nanocomposites for cancer cells detection and targeted drug delivery. Anal Chim Acta. 2018;1027:109–120. doi:10.1016/j.aca.2018.04.02929866260
  • Hussien NA, Işıklan N, Türk M. Aptamer-functionalized magnetic graphene oxide nanocarrier for targeted drug delivery of paclitaxel. Mater Chem Phys. 2018;211:479–488. doi:10.1016/j.matchemphys.2018.03.015
  • Gong P, Ji S, Wang J, et al. Fluorescence-switchable ultrasmall fluorinated graphene oxide with high near-infrared absorption for controlled and targeted drug delivery. Chem Eng J. 2018;348:438–446. doi:10.1016/j.cej.2018.04.193
  • Ratajczak K, Stobiecka M. Ternary interactions and energy transfer between fluorescein isothiocyanate, adenosine triphosphate, and graphene oxide nanocarriers. J Phys Chem B. 2017;121(28):6822–6830. doi:10.1021/acs.jpcb.7b0429528650635
  • Itatahine A, Mehdi YA, Fizir M, Qi M, Dramou P, He H. Multifunctional carbon nanomateriels for camptothecine low-water soluble anticancer drug delivery. N J Chem. 2018;42(2):1326–1336. doi:10.1039/C7NJ04609J
  • Deb A, Andrews NG, Raghavan V. Natural polymer functionalized graphene oxide for co-delivery of anticancer drugs: in-vitro and in-vivo. Int J Biol Macromol. 2018;113:515–525. doi:10.1016/j.ijbiomac.2018.02.15329496437
  • Zare-Zardini H, Taheri-Kafrani A, Amiri A, Bordbar AK. New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity. Sci Rep. 2018;8(1):1–15. doi:10.1038/s41598-017-18938-y29311619
  • Javanbakht S, Namazi H. Doxorubicin loaded carboxymethyl cellulose/graphene quantum dot nanocomposite hydrogel films as a potential anticancer drug delivery system. Mater Sci Eng C. 2018;87:50–59. doi:10.1016/j.msec.2018.02.010
  • Li Y, Gao X, Yu Z, et al. Reversing multidrug resistance by multiplexed gene silencing for enhanced breast cancer chemotherapy. ACS Appl Mater Interfaces. 2018;10(18):15461–15466. doi:10.1021/acsami.8b0280029663807
  • Xie M, Zhang F, Liu L, et al. Surface modification of graphene oxide nanosheets by protamine sulfate/sodium alginate for anti-cancer drug delivery application. Appl Surf Sci. 2018;440:853–860. doi:10.1016/j.apsusc.2018.01.175
  • Puvirajesinghe TM, Zhi Z, Craster R, Guenneau S. Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide. J R Soc Interface. 2018;15(139):20170949. doi:10.1098/rsif.2017.094929445040
  • Rao Z, Ge H, Liu L, et al. Carboxymethyl cellulose modified graphene oxide as pH-sensitive drug delivery system. Int J Biol Macromol. 2018;107:1184–1192. doi:10.1016/j.ijbiomac.2017.09.09628951302
  • Deb A, Vimala R. Camptothecin loaded graphene oxide nanoparticle functionalized with polyethylene glycol and folic acid for anticancer drug delivery. J Drug Deliv Sci Technol. 2018;43(October2017):333–342. doi:10.1016/j.jddst.2017.10.025
  • de Sousa M, Visani de Luna LA, Fonseca LC, Giorgio S, Alves OL. Folic-acid-functionalized graphene oxide nanocarrier: synthetic approaches, characterization, drug delivery study, and antitumor screening. ACS Appl Nano Mater. 2018;1(2):922–932. doi:10.1021/acsanm.7b00324
  • Karimi M, Eslami M, Sahandi‐Zangabad P, et al. pH‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016;8(5):696–716.26762467
  • Roointan A, Farzanfar J, Mohammadi-Samani S, Behzad-Behbahani A, Farjadian F. Smart pH responsive drug delivery system based on poly (HEMA-co-DMAEMA) nanohydrogel. Int J Pharm. 2018;552(1–2):301–311. doi:10.1016/j.ijpharm.2018.10.00130291961
  • Mozafari N, Farjadian F, Samani SM, Azadi S, Azadi A. Simvastatin-chitosan-citicoline conjugates nanoparticles as the co-delivery system in Alzheimer susceptible patients. Int J Biol Macromol. 2020;156:1396–1407. doi:10.1016/j.ijbiomac.2019.11.18031760027
  • Kavitha T, Abdi SIH, Park S-Y. pH-sensitive nanocargo based on smart polymer functionalized graphene oxide for site-specific drug delivery. Phys Chem Chem Phys. 2013;15(14):5176–5185. doi:10.1039/c3cp00008g23454895
  • Wang C, Chen B, Zou M, Cheng G. Cyclic RGD-modified chitosan/graphene oxide polymers for drug delivery and cellular imaging. Colloids Surf B Biointerfaces. 2014;122:332–340. doi:10.1016/j.colsurfb.2014.07.01825064484
  • Feng L, Li K, Shi X, Gao M, Liu J, Liu Z. Smart pH‐responsive nanocarriers based on nano‐graphene oxide for combined chemo‐and photothermal therapy overcoming drug resistance. Adv Healthcare Mater. 2014;3(8):1261–1271. doi:10.1002/adhm.201300549
  • Jiang T, Sun W, Zhu Q, et al. Furin‐mediated sequential delivery of anticancer cytokine and small‐molecule drug shuttled by graphene. Adv Mater. 2015;27(6):1021–1028. doi:10.1002/adma.20140449825504623
  • Lv O, Tao Y, Qin Y, et al. Highly fluorescent and morphology-controllable graphene quantum dots-chitosan hybrid xerogels for in vivo imaging and pH-sensitive drug carrier. Mater Sci Eng C. 2016;67:478–485. doi:10.1016/j.msec.2016.05.031
  • Qiu J, Zhang R, Li J, et al. Fluorescent graphene quantum dots as traceable, pH-sensitive drug delivery systems. Int J Nanomedicine. 2015;10:6709.26604747
  • Huang Y-S, Lu Y-J, Chen J-P. Magnetic graphene oxide as a carrier for targeted delivery of chemotherapy drugs in cancer therapy. J Magn Magn Mater. 2016.
  • Tyagi N, Attia NF, Geckeler KE. Exfoliated graphene nanosheets: pH-sensitive drug carrier and anti-cancer activity. J Colloid Interface Sci. 2017;498:364–377. doi:10.1016/j.jcis.2017.03.05728343134
  • Javanbakht S, Shaabani A. Encapsulation of graphene quantum dot-crosslinked chitosan by carboxymethylcellulose hydrogel beads as a pH-responsive bio-nanocomposite for the oral delivery agent. Int J Biol Macromol. 2019;123:389–397. doi:10.1016/j.ijbiomac.2018.11.11830445077
  • Dong J, Wang K, Sun L, et al. Application of graphene quantum dots for simultaneous fluorescence imaging and tumor-targeted drug delivery. Sens Actuators B Chem. 2018;256:616–623. doi:10.1016/j.snb.2017.09.200
  • Sumathra M, Sadasivuni KK, Kumar SS, Rajan M. Cisplatin-Loaded graphene oxide/chitosan/hydroxyapatite composite as a promising tool for osteosarcoma-affected bone regeneration. ACS Omega. 2018;3(11):14620–14633. doi:10.1021/acsomega.8b0209030555982
  • Vinothini K, Rajendran NK, Rajan M, Ramu A, Marraiki N, Elgorban AM. A magnetic nanoparticle functionalized reduced graphene oxide-based drug carrier system for a chemo-photodynamic cancer therapy. N J Chem. 2020;44(14):5265–5277. doi:10.1039/D0NJ00049C
  • Vinothini K, Rajendran NK, Ramu A, Elumalai N, Rajan M. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier. Biomedicine Pharmacother. 2019;110:906–917. doi:10.1016/j.biopha.2018.12.008
  • Vinothini K, Rajendran NK, Munusamy MA, Alarfaj AA, Rajan M. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier. Mater Sci Eng C. 2019;100:676–687. doi:10.1016/j.msec.2019.03.011
  • Prabakaran S, Jeyaraj M, Nagaraj A, Sadasivuni KK, Rajan M. Polymethyl methacrylate–ovalbumin@ graphene oxide drug carrier system for high anti-proliferative cancer drug delivery. Applied Nanosci. 2019;9(7):1487–1500. doi:10.1007/s13204-019-00950-5
  • Luo Y, Tang Y, Liu T, et al. Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics. Chem Commun. 2019;55(13):1963–1966. doi:10.1039/C8CC09185D
  • Kazempour M, Namazi H, Akbarzadeh A, Kabiri R. Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier. Artif Cells Nanomed Biotechnol. 2019;47(1):90–94. doi:10.1080/21691401.2018.154319630663418
  • Kundu A, Nandi S, Das P, Nandi AK. Fluorescent graphene oxide via polymer grafting: an efficient nanocarrier for both hydrophilic and hydrophobic drugs. ACS Appl Mater Interfaces. 2015;7(6):3512–3523. doi:10.1021/am507110r25612470
  • Onuki Y, Bhardwaj U, Papadimitrakopoulos F, Burgess DJ. A Review of the Biocompatibility of Implantable Devices: Current Challenges to Overcome Foreign Body Response. SAGE Publications; 2008.
  • Romberg B, Hennink WE, Storm G. Sheddable coatings for long-circulating nanoparticles. Pharm Res. 2008;25(1):55–71. doi:10.1007/s11095-007-9348-717551809
  • Meng F, Hennink WE, Zhong Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials. 2009;30(12):2180–2198. doi:10.1016/j.biomaterials.2009.01.02619200596
  • Wen H, Dong C, Dong H, et al. Engineered redox‐responsive PEG detachment mechanism in PEGylated nano‐graphene oxide for intracellular drug delivery. Small. 2012;8(5):760–769. doi:10.1002/smll.20110161322228696
  • Chen H, Wang Z, Zong S, et al. SERS-fluorescence monitored drug release of a redox-responsive nanocarrier based on graphene oxide in tumor cells. ACS Appl Mater Interfaces. 2014;6(20):17526–17533. doi:10.1021/am505160v25272041
  • Zhao X, Yang L, Li X, et al. Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug. Bioconjug Chem. 2015;26(1):128–136. doi:10.1021/bc500513725525819
  • Al-Nahain A, Lee SY, In I, Lee KD, Park SY. Triggered pH/redox responsive release of doxorubicin from prepared highly stable graphene with thiol grafted pluronic. Int J Pharm. 2013;450(1):208–217. doi:10.1016/j.ijpharm.2013.04.05323624082
  • Cho Y, Choi Y. Graphene oxide–photosensitizer conjugate as a redox-responsive theranostic agent. Chem Commun. 2012;48(79):9912–9914. doi:10.1039/c2cc35197h
  • Yin T, Liu J, Zhao Z, et al. Redox sensitive hyaluronic acid-decorated graphene oxide for photothermally controlled tumor-cytoplasm-selective rapid drug delivery. Adv Funct Mater. 2017;27(14):1604620. doi:10.1002/adfm.201604620
  • Kim DJ, Kim J, Lee HL, et al. Redox-responsive nanocomposites composed of graphene oxide and chlorin e6 for photodynamic treatment of cholangiocarcinoma. Bull Korean Chem Soc. 2018;39(9):1073–1082. doi:10.1002/bkcs.11552
  • Liu J, Zhang D, Lian S, et al. Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs. Int J Nanomedicine. 2018;13:7457. doi:10.2147/IJN.S17388930532533
  • Ma N, Song A, Li Z, Luan Y. Redox-sensitive prodrug molecules meet graphene oxide: an efficient graphene oxide-based nanovehicle toward cancer therapy. ACS Biomater Sci Eng. 2019;5(3):1384–1391. doi:10.1021/acsbiomaterials.9b0011433405614
  • Farjadian F, Rezaeifard S, Naeimi M, et al. Temperature and pH-responsive nano-hydrogel drug delivery system based on lysine-modified poly (vinylcaprolactam). Int J Nanomedicine. 2019;14:6901. doi:10.2147/IJN.S21446731564860
  • Farjadian F, Ghasemi S, Andami Z, Tamami B. Thermo-responsive nanocarrier based on poly (N-isopropylacrylamide) serving as a smart doxorubicin delivery system. Iranian Polymer J. 2020;29(3):197–207. doi:10.1007/s13726-020-00785-w
  • Zhu S, Li J, Chen Y, et al. Grafting of graphene oxide with stimuli-responsive polymers by using ATRP for drug release. J Nanoparticle Res. 2012;14(9):1–11. doi:10.1007/s11051-012-1132-x
  • Wang H, Sun D, Zhao N, et al. Thermo-sensitive graphene oxide–polymer nanoparticle hybrids: synthesis, characterization, biocompatibility and drug delivery. J Mater Chem B. 2014;2(10):1362–1370.32261451
  • Pan Y, Bao H, Sahoo NG, Wu T, Water‐Soluble Poly LL. (N‐isopropylacrylamide)–graphene sheets synthesized via click chemistry for drug delivery. Adv Funct Mater. 2011;21(14):2754–2763. doi:10.1002/adfm.201100078
  • Bardajee GR, Hooshyar Z, Farsi M, Mobini A, Sang G. Synthesis of a novel thermo/pH sensitive nanogel based on salep modified graphene oxide for drug release. Mater Sci Eng C. 2016.
  • Wang C, Mallela J, Garapati USet al., A chitosan-modified graphene nanogel for noninvasive controlled drug release. Nanomedicine. 2013;9(7):903–911. doi:10.1016/j.nano.2013.01.00323352802
  • Wang P, Chen S, Cao Z, Wang G, Light- NIR. Temperature-, pH-, and redox-responsive polymer-modified reduced graphene oxide/mesoporous silica sandwich-like nanocomposites for controlled release. ACS Appl Mater Interfaces. 2017;9(34):29055–29062. doi:10.1021/acsami.7b0746828795557
  • Khoee S, Karimi MR. Dual-drug loaded Janus graphene oxide-based thermoresponsive nanoparticles for targeted therapy. Polymer. 2018;142:80–98. doi:10.1016/j.polymer.2018.03.022
  • Havanur S, Batish I, Cheruku SP, Gourishetti K, Kumar PEJ. N. Poly(N,N-diethyl acrylamide)/functionalized graphene quantum dots hydrogels loaded with doxorubicin as a nano-drug carrier for metastatic lung cancer in mice. Mater Sci Eng C. 2019;105:110094. doi:10.1016/j.msec.2019.110094
  • Farjadian F, Ghasemi S, Mohammadi-Samani S. Hydroxyl-modified magnetite nanoparticles as novel carrier for delivery of methotrexate. Int J Pharm. 2016;504(1–2):110–116. doi:10.1016/j.ijpharm.2016.03.02226994523
  • Yang X, Wang Y, Huang X, et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J Mater Chem. 2011;21(10):3448–3454. doi:10.1039/C0JM02494E
  • Wang Z, Zhou C, Xia J, et al. Fabrication and characterization of a triple functionalization of graphene oxide with Fe 3 O 4, folic acid and doxorubicin as dual-targeted drug nanocarrier. Colloids Surf B Biointerfaces. 2013;106:60–65. doi:10.1016/j.colsurfb.2013.01.03223434692
  • Swain AK, Pradhan L, Bahadur D. Polymer stabilized Fe3O4-graphene as an amphiphilic drug carrier for thermo-chemotherapy of cancer. ACS Appl Mater Interfaces. 2015;7(15):8013–8022. doi:10.1021/acsami.5b0253625821899
  • Ma X, Tao H, Yang K, et al. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res. 2012;5(3):199–212. doi:10.1007/s12274-012-0200-y
  • Wang C, Ravi S, Garapati USet al., Multifunctional chitosan magnetic-graphene (CMG) nanoparticles: a theranostic platform for tumor-targeted co-delivery of drugs, genes and MRI contrast agents. J Mater Chem B. 2013;1(35):4396–4405. doi:10.1039/c3tb20452a24883188
  • Guo L, Shi H, Wu H, et al. Prostate cancer targeted multifunctionalized graphene oxide for magnetic resonance imaging and drug delivery. Carbon. 2016;107:87–99. doi:10.1016/j.carbon.2016.05.054
  • Wang C, Li B, Niu W, et al. β-Cyclodextrin modified graphene oxide–magnetic nanocomposite for targeted delivery and pH-sensitive release of stereoisomeric anti-cancer drugs. RSC Adv. 2015;5(108):89299–89308. doi:10.1039/C5RA13082D
  • Xie M, Zhang F, Peng H, et al. Layer-by-layer modification of magnetic graphene oxide by chitosan and sodium alginate with enhanced dispersibility for targeted drug delivery and photothermal therapy. Colloids Surf B Biointerfaces. 2019;176:462–470. doi:10.1016/j.colsurfb.2019.01.02830682619
  • Bardajee GR, Hooshyar Z. Thermo/pH/magnetic-triple sensitive poly(N-isopropylacrylamide-co-2-dimethylaminoethyl) methacrylate)/sodium alginate modified magnetic graphene oxide nanogel for anticancer drug delivery. Polymer Bull. 2018;75(12):5403–5419. doi:10.1007/s00289-018-2329-7
  • Shirvalilou S, Khoei S, Khoee S, Raoufi NJ, Karimi MR, Shakeri-Zadeh A. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: in vitro and in vivo evaluations. Chem Biol Interact. 2018;295:97–108. doi:10.1016/j.cbi.2018.08.02730170108
  • Gupta J, Prakash A, Jaiswal MK, Agarrwal A, Bahadur D. Superparamagnetic iron oxide-reduced graphene oxide nanohybrid-a vehicle for targeted drug delivery and hyperthermia treatment of cancer. J Magn Magn Mater. 2018;448:332–338. doi:10.1016/j.jmmm.2017.05.084
  • Bao Z, Liu X, Liu Y, Liu H, Zhao K. Near-infrared light-responsive inorganic nanomaterials for photothermal therapy. Asian J Pharm Sci. 2016;11(3):349–364. doi:10.1016/j.ajps.2015.11.123
  • Tian B, Wang C, Zhang S, Feng L, Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano. 2011;5(9):7000–7009. doi:10.1021/nn201560b21815655
  • Zhou L, Jiang H, Wei S, Ge X, Zhou J, Shen J. High-efficiency loading of hypocrellin B on graphene oxide for photodynamic therapy. Carbon. 2012;50(15):5594–5604. doi:10.1016/j.carbon.2012.08.013
  • Wang Y, Wang H, Liu D, Song S, Wang X, Zhang H. Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy. Biomaterials. 2013;34(31):7715–7724. doi:10.1016/j.biomaterials.2013.06.04523859660
  • Tran TH, Nguyen HT, Pham TT, et al. Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer. ACS Appl Mater Interfaces. 2015;7(51):28647–28655. doi:10.1021/acsami.5b1042626641922
  • Shi J, Wang L, Zhang J, et al. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@ Ag nanoparticles for chemo-photothermal therapy and X-ray imaging. Biomaterials. 2014;35(22):5847–5861. doi:10.1016/j.biomaterials.2014.03.04224746963
  • Chen J, Liu H, Zhao C, et al. One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery. Biomaterials. 2014;35(18):4986–4995. doi:10.1016/j.biomaterials.2014.02.03224656608
  • Song J, Yang X, Jacobson O, et al. Sequential drug release and enhanced photothermal and photoacoustic effect of hybrid reduced graphene oxide-loaded ultrasmall gold nanorod vesicles for cancer therapy. ACS Nano. 2015;9(9):9199–9209. doi:10.1021/acsnano.5b0380426308265
  • Chen L, Zhong X, Yi X, et al. Radionuclide 131 I labeled reduced graphene oxide for nuclear imaging guided combined radio-and photothermal therapy of cancer. Biomaterials. 2015;66:21–28. doi:10.1016/j.biomaterials.2015.06.04326188609
  • Feng L, Yang X, Shi X, et al. Polyethylene glycol and polyethylenimine dual‐functionalized nano‐graphene oxide for photothermally enhanced gene delivery. Small. 2013;9(11):1989–1997. doi:10.1002/smll.20120253823292791
  • Liu W, Zhang X, Zhou L, Shang L, Su Z. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy. J Colloid Interface Sci. 2019;536:160–170. doi:10.1016/j.jcis.2018.10.05030366181
  • Huang C, Hu X, Hou Z, Ji J, Li Z, Luan Y. Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy. J Colloid Interface Sci. 2019;545:172–183. doi:10.1016/j.jcis.2019.03.01930878783
  • Zhang Y, Zhang H, Wang Z, Jin Y. pH-Sensitive graphene oxide conjugate purpurin-18 methyl ester photosensitizer nanocomplex in photodynamic therapy. N J Chem. 2018;42(16):13272–13284. doi:10.1039/C8NJ00439K
  • Du B, Liu J, Ding Get al., Positively charged graphene/Fe3O4/polyethylenimine with enhanced drug loading and cellular uptake for magnetic resonance imaging and magnet-responsive cancer therapy. Nano Res. 2017;10(7):2280–2295. doi:10.1007/s12274-016-1418-x
  • Chang G, Li S, Huang F, Zhang X, Shen Y, Xie A. Multifunctional reduced graphene oxide hydrogel as drug carrier for localized and synergic photothermal/photodynamics/chemo therapy. J Mater Sci Technol. 2016;32(8):753–762. doi:10.1016/j.jmst.2016.06.014
  • Sahu A, Choi WI, Lee JH, Tae G. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials. 2013;34(26):6239–6248. doi:10.1016/j.biomaterials.2013.04.06623706688
  • Wei Y, Zhou F, Zhang D, Chen Q, Xing D. A graphene oxide based smart drug delivery system for tumor mitochondria-targeting photodynamic therapy. Nanoscale. 2016;8(6):3530–3538. doi:10.1039/C5NR07785K26799192
  • Li Y, Wu Z, Du D, Dong H, Shi D, Li Y. A graphene quantum dot (GQD) nanosystem with redox-triggered cleavable PEG shell facilitating selective activation of the photosensitiser for photodynamic therapy. RSC Adv. 2016;6(8):6516–6522. doi:10.1039/C5RA23622C
  • Lee JS, Kim S, Na HK, Min DH. MicroRNA‐responsive drug release system for selective fluorescence imaging and photodynamic therapy in vivo. Adv Healthcare Mater. 2016;5(18):2386–2395. doi:10.1002/adhm.201600328
  • Su T, Cheng F, Yan J, et al. Hierarchical nanocomposites of graphene oxide and PEGylated protoporphyrin as carriers to load doxorubicin hydrochloride for trimodal synergistic therapy. J Mater Chem B. 2018;6(28):4687–4696. doi:10.1039/C8TB00733K32254413
  • Ju J, Regmi S, Fu A, Lim S, Liu Q. Graphene quantum dot based charge-reversal nanomaterial for nucleus-targeted drug delivery and efficiency controllable photodynamic therapy. J Biophoton. 2019;12(6):e201800367. doi:10.1002/jbio.201800367
  • Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov. 2005;4(7):581. doi:10.1038/nrd177516052241
  • Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329–347. doi:10.1016/S0169-409X(02)00228-412628320
  • Xiang Y, Oo NNL, Lee JP, Li Z, Loh XJ. Recent development of synthetic nonviral systems for sustained gene delivery. Drug Discov Today. 2017;22(9):1318–1335. doi:10.1016/j.drudis.2017.04.00128428056
  • Midoux P, Pichon C, Yaouanc JJ, Jaffrès PA. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol. 2009;157(2):166–178. doi:10.1111/j.1476-5381.2009.00288.x19459843
  • Farjadian F, Moghoofei M, Mirkiani S, et al. Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: set the bugs to work? Biotechnol Adv. 2018;36(4):968–985. doi:10.1016/j.biotechadv.2018.02.01629499341
  • Wong JK, Mohseni R, Hamidieh AA, MacLaren RE, Habib N, Seifalian AM. Will nanotechnology bring new hope for gene delivery? Trends Biotechnol. 2017;35(5):434–451. doi:10.1016/j.tibtech.2016.12.00928108036
  • Karimi M, Solati N, Ghasemi A, et al. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery. Expert Opin Drug Deliv. 2015;12(7):1089–1105. doi:10.1517/17425247.2015.100430925613837
  • Chandrasekhar P. Medical and pharmaceutical applications of graphene In: Dalton, editor. Conducting Polymers, Fundamentals and Applications. Springer; 2018:149–150.
  • Zhi F, Dong H, Jia X, et al. Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro. PLoS One. 2013;8(3):e60034. doi:10.1371/journal.pone.006003423527297
  • Goncalves G, Marques P, Vila M. Graphene-Based Materials in Health and Environment. Springer; 2017.
  • Jian H-J, Wu R-S, Lin T-Y, et al. Super-cationic carbon quantum dots synthesized from spermidine as an eye drop formulation for topical treatment of bacterial keratitis. ACS Nano. 2017;11(7):6703–6716. doi:10.1021/acsnano.7b0102328677399
  • Lam P-L, Wong W-Y, Bian Z, Chui C-H GR. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern. Nanomedicine. 2017;12(4):357–385. doi:10.2217/nnm-2016-030528078952
  • Teimouri M, Nia AH, Abnous K, Eshghi H, Ramezani M. Graphene oxide–cationic polymer conjugates: synthesis and application as gene delivery vectors. Plasmid. 2016;84:51–60. doi:10.1016/j.plasmid.2016.03.00227072918
  • Zhou X, Laroche F, Lamers GE, et al. Ultra-small graphene oxide functionalized with polyethylenimine (PEI) for very efficient gene delivery in cell and zebrafish embryos. Nano Res. 2012;5(10):703–709. doi:10.1007/s12274-012-0254-x
  • Hu H, Tang C, Yin C. Folate conjugated trimethyl chitosan/graphene oxide nanocomplexes as potential carriers for drug and gene delivery. Mater Lett. 2014;125:82–85. doi:10.1016/j.matlet.2014.03.133
  • Zhu X, Zhang Y, Huang H, Zhang H, Hou L, Zhang Z. Functionalized graphene oxide-based thermosensitive hydrogel for near-infrared chemo-photothermal therapy on tumor. J Biomater Appl. 2016;30(8):1230–1241. doi:10.1177/088532821561958326759390
  • Bao H, Pan Y, Ping Yet al., Chitosan‐functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small. 2011;7(11):1569–1578. doi:10.1002/smll.20110019121538871
  • Liu X, Ma D, Tang H, et al. Polyamidoamine dendrimer and oleic acid-functionalized graphene as biocompatible and efficient gene delivery vectors. ACS Appl Mater Interfaces. 2014;6(11):8173–8183. doi:10.1021/am500812h24836601
  • Kou Z, Wang X, Yuan R, et al. A promising gene delivery system developed from PEGylated MoS 2 nanosheets for gene therapy. Nanoscale Res Lett. 2014;9(1):587. doi:10.1186/1556-276X-9-58725386104
  • Feng L, Zhang S, Liu Z. Graphene based gene transfection. Nanoscale. 2011;3(3):1252–1257. doi:10.1039/c0nr00680g21270989
  • Cao X, Zheng S, Zhang S, et al. Functionalized graphene oxide with hepatocyte targeting as anti-tumor drug and gene intracellular transporters. J Nanosci Nanotechnol. 2015;15(3):2052–2059. doi:10.1166/jnn.2015.914526413620
  • Fan Z, Fu PP, Yu H, Ray PC. Theranostic nanomedicine for cancer detection and treatment. J Food Drug Anal. 2014;22(1):3–17. doi:10.1016/j.jfda.2014.01.00124673900
  • Fan Z, Senapati D, Singh AK, Ray PC. Theranostic magnetic core-plasmonic shell star shape nanoparticle for the isolation of targeted rare tumor cells from whole blood, fluorescence imaging, and photothermal destruction of cancer. Mol Pharm. 2013;10(3):857–866. doi:10.1021/mp300468q23110457
  • Li J, Lyv Z, Li Y, et al. A theranostic prodrug delivery system based on Pt (IV) conjugated nano-graphene oxide with synergistic effect to enhance the therapeutic efficacy of Pt drug. Biomaterials. 2015;51:12–21. doi:10.1016/j.biomaterials.2015.01.07425770993
  • Gorgizadeh M, Azarpira N, Sattarahmady N. In vitro and in vivo tumor annihilation by near-infrared photothermal effect of a NiFe2O4/C nanocomposite. Colloids Surf B Biointerfaces. 2018;170:393–400.29945051
  • Luo Y, Li Z, Zhu C, et al. Graphene-like metal-free 2D nanosheets for cancer imaging and theranostics. Trends Biotechnol. 2018;36(11):1145–1156. doi:10.1016/j.tibtech.2018.05.01229954613
  • Chen H, Liu F, Lei Z, Ma L, Wang Z. Fe2O3@Au core@shell nanoparticle–graphene nanocomposites as theranostic agents for bioimaging and chemo-photothermal synergistic therapy. RSC Adv. 2015;5(103):84980–84987. doi:10.1039/C5RA17143A
  • Bahreyni A, Yazdian-Robati R, Hashemitabar S, et al. A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells. Int J Pharm. 2017;526(1–2):391–399. doi:10.1016/j.ijpharm.2017.05.01428495579
  • Yang K, Hu L, Ma X, et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater. 2012;24(14):1868–1872. doi:10.1002/adma.20110496422378564
  • Lamb J, Fischer E, Rosillo-Lopez M, Salzmann CG, Holland JP. Multi-functionalised graphene nanoflakes as tumour-targeting theranostic drug-delivery vehicles. Chem Sci. 2019;10(38):8880–8888. doi:10.1039/C9SC03736E32874485
  • Karki N, Rana A, Tiwari H, Negi P, Sahoo NG. Theranostics application of graphene-based materials in cancer imaging, targeting and treatment In: Lasfar A, Cohen-Solal K, editors. Tumor Progression and Metastasis. IntechOpen; 2020.
  • Janib SM, Moses AS, MacKay JA. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev. 2010;62(11):1052–1063. doi:10.1016/j.addr.2010.08.00420709124
  • Bao X, Yuan Y, Chen J, et al. In vivo theranostics with near-infrared-emitting carbon dots—highly efficient photothermal therapy based on passive targeting after intravenous administration. Light. 2018;7(1):1–11. doi:10.1038/s41377-018-0090-1
  • Pramanik A, Chavva SR, Fan Z, Sinha SS, Nellore BPV, Ray PC. Extremely high two-photon absorbing graphene oxide for imaging of tumor cells in the second biological window. J Phys Chem Lett. 2014;5(12):2150–2154. doi:10.1021/jz500985626270507
  • Yang Y, Wang S, Wang C, Tian C, Shen Y, Zhu M. Engineered targeted hyaluronic acid–glutathione‐stabilized gold nanoclusters/graphene oxide–5‐fluorouracil as a smart theranostic platform for stimulus‐controlled fluorescence imaging‐assisted synergetic chemo/phototherapy. Chem Asian J. 2019;14(9):1418–1423. doi:10.1002/asia.20190015330829452
  • Prasad R, Yadav AS, Gorain M, et al. Graphene oxide supported liposomes as red emissive theranostics for phototriggered tissue visualization and tumor regression. ACS Appl Bio Mater. 2019;2(8):3312–3320. doi:10.1021/acsabm.9b00335
  • Kumawat MK, Thakur M, Bahadur R, et al. Preparation of graphene oxide-graphene quantum dots hybrid and its application in cancer theranostics. Mater Sci Eng C. 2019;103:109774. doi:10.1016/j.msec.2019.109774
  • Lui CH, Mak KF, Shan J, Heinz TF. Ultrafast photoluminescence from graphene. Phys Rev Lett. 2010;105(12):127404. doi:10.1103/PhysRevLett.105.12740420867672
  • Xu X, Liu C, Sun Z, et al. Interfacial engineering in graphene bandgap. Chem Soc Rev. 2018;47(9):3059–3099.29513306
  • Xiong J, Yang Q, Li J, Zhou S. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer. Angiogenesis. 2014;17(1):37–50. doi:10.1007/s10456-013-9376-323907365
  • Khurana R, Simons M, Martin JF, Zachary IC. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation. 2005;112(12):1813–1824. doi:10.1161/CIRCULATIONAHA.105.53529416172288
  • Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. nature. 2000;407(6801):249–257. doi:10.1038/3502522011001068
  • Mukherjee S, Sriram P, Barui AK, et al. Graphene oxides show angiogenic properties. Adv Healthcare Mater. 2015;4(11):1722–1732. doi:10.1002/adhm.201500155
  • Qian Y, Song J, Zhao X, et al. 3D fabrication with integration molding of a graphene oxide/polycaprolactone nanoscaffold for neurite regeneration and angiogenesis. Advan Sci. 2018;5(4):1700499. doi:10.1002/advs.201700499
  • Sun Z, Huang P, Tong G, et al. VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle. Nanoscale. 2013;5(15):6857–6866. doi:10.1039/c3nr01573d23770832
  • Paul A, Hasan A, Kindi HA, et al. Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair. ACS Nano. 2014;8(8):8050–8062. doi:10.1021/nn502078724988275
  • Xue D, Chen E, Zhong H, et al. Immunomodulatory properties of graphene oxide for osteogenesis and angiogenesis. Int J Nanomedicine. 2018;13:5799. doi:10.2147/IJN.S17030530310282
  • Ur Rehman SR, Augustine R, Zahid AA, et al. Reduced graphene oxide incorporated GelMA hydrogel promotes angiogenesis for wound healing applications. Int J Nanomedicine. 2019;14(9603):9603–9617. doi:10.2147/IJN.S21812031824154
  • Shim G, Kim J-Y, Han J, et al. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs. J Controlled Release. 2014;189:80–89. doi:10.1016/j.jconrel.2014.06.026
  • Lai P-X, Chen C-W, Wei S-C, et al. Ultrastrong trapping of VEGF by graphene oxide: anti-angiogenesis application. Biomaterials. 2016;109:12–22. doi:10.1016/j.biomaterials.2016.09.00527639528
  • Cibecchini G, Veronesi M, Catelani T, Bandiera T, Guarnieri D, Pompa PP. Antiangiogenic effect of graphene oxide in primary human endothelial cells. ACS Appl Mater Interfaces. 2020;12(20):22507–22518.32255338
  • Wierzbicki M, Sawosz E, Strojny B, Jaworski S, Grodzik M, Chwalibog A. NF-κB-related decrease of glioma angiogenic potential by graphite nanoparticles and graphene oxide nanoplatelets. Sci Rep. 2018;8(1):1–9. doi:10.1038/s41598-018-33179-329311619
  • Li J, Ge X, Cui C, et al. Preparation and characterization of functionalized graphene oxide carrier for siRNA delivery. Int J Mol Sci. 2018;19(10):3202. doi:10.3390/ijms19103202
  • Stone V, Johnston H, Schins RPF. Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol. 2009;39(7):613–626. doi:10.1080/1040844090312097519650720
  • Liu K, Zhang -J-J, Cheng -F-F, Zheng -T-T, Wang C, Zhu -J-J. Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. J Mater Chem. 2011;21(32):12034–12040. doi:10.1039/c1jm10749f
  • Sanchez VC, Pietruska JR, Miselis NR, Hurt RH, Kane AB. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(5):511–529.20049814
  • Dreyer DR, Park S, Bielawski CW, Ruoff RS. The chemistry of graphene oxide. Chem Soc Rev. 2010;39(1):228–240. doi:10.1039/B917103G20023850
  • Muthoosamy K, Abubakar IB, Bai RG, Loh H-S, Manickam S. Exceedingly higher co-loading of curcumin and paclitaxel onto polymer-functionalized reduced graphene oxide for highly potent synergistic anticancer treatment. Sci Rep. 2016;6:32808. doi:10.1038/srep3280827597657
  • Cho YC, Pak PJ, Joo YH, Lee H-S CN. In vitro and in vivo comparison of the immunotoxicity of single- and multi-layered graphene oxides with or without pluronic F-127. Sci Rep. 2016;6:38884. doi:10.1038/srep3888427941848
  • Zhao M-L, Liu X-Q, Cao Y, et al. Enhancement of interaction of L-929 cells with functionalized graphene via COOH+ ion implantation vs. chemical method. Sci Rep. 2016;6:37112. doi:10.1038/srep3711227845420
  • Vuppaladadium SSR, Agarwal T, Kulanthaivel S, et al. Silanization improves biocompatibility of graphene oxide. Mater Sci Eng C. 2020;110:110647. doi:10.1016/j.msec.2020.110647
  • Sydlik SA, Jhunjhunwala S, Webber MJ, Anderson DG, Langer R. In vivo compatibility of graphene oxide with differing oxidation states. ACS Nano. 2015;9(4):3866–3874. doi:10.1021/acsnano.5b0129025849074
  • Zhang X, Yin J, Peng C, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. carbon. 2011;49(3):986–995. doi:10.1016/j.carbon.2010.11.005
  • Nurunnabi M, Khatun Z, Huh KM, et al. In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano. 2013;7(8):6858–6867. doi:10.1021/nn402043c23829293
  • Yang K, Zhang S, Zhang G, Sun X, Lee S-T LZ. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010;10(9):3318–3323. doi:10.1021/nl100996u20684528
  • Reina G, González-Domínguez JM, Criado A, Vázquez E, Bianco A, Prato M. Promises, facts and challenges for graphene in biomedical applications. Chem Soc Rev. 2017;46(15):4400–4416. doi:10.1039/C7CS00363C28722038
  • Bianco A. Graphene: safe or toxic? The two faces of the medal. Angewandte Chemie Int Ed. 2013;52(19):4986–4997. doi:10.1002/anie.201209099
  • Zhang Y, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano. 2010;4(6):3181–3186. doi:10.1021/nn100717620481456